News Coverage 07.28.20 Share on Twitter Share on Facebook Share on LinkedIn Pandemic Inspires Impactful Public-Private Partnerships If COVID-19 has an upside, it’s that the public health crisis has turned fierce competitors unto friendly collaborators and forged unlikely partnerships between groups who tackle problems from a different angle. The biopharmaceutical industry, charitable foundations, academia, and government agencies have come together in unprecedented ways, hoping to break time records in learning how to diagnose, prevent, and treat a new disease. Related Announcement PICI Hosts 2024 Spring Scientific Retreat Press Release BostonGene and the Parker Institute for Cancer Immunotherapy Collaborate to Generate Comprehensive Longitudinal Multi-Omic Data for Predicting Immunotherapy Outcomes Announcement, From Bench to Fireside Episode Nine: Katie Campbell, PhD
Press Release BostonGene and the Parker Institute for Cancer Immunotherapy Collaborate to Generate Comprehensive Longitudinal Multi-Omic Data for Predicting Immunotherapy Outcomes